Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue	$ 3,867,926	$ 2,336,489
Cost of revenue	1,289,862	623,152
Gross profit	2,578,064	1,713,337
Operating expenses:
Research and development	659,536	525,967
Selling, general and administrative	4,656,417	4,119,802
Total operating expenses	5,315,953	4,645,769
Loss from operations	(2,737,889)	(2,932,432)
Other expense
Other expense, including interest income, net	790	119
Total other expense (income)	790	119
Loss before income taxes	(2,738,679)	(2,932,551)
Income tax expense	76,255	28,243
Net loss	$ (2,814,934)	$ (2,960,794)
Weighted average number of common shares outstanding:
Basic and diluted	6,885,924	5,191,417
Net loss per share attributable to common stockholders
Basic and diluted	$ (0.41)	$ (0.57)
Product Revenue
Revenue	$ 2,867,926	$ 2,336,489
License Revenue
Revenue	$ 1,000,000